Clinical Topics & News

Depression Screening and Treatment: A Missed Opportunity in Lung Cancer Care

Author and Disclosure Information

 

References

Overall, there is minimal evidence that depression treatment can improve lung cancer survival; however, the lack of high-quality studies is a considerable limitation. Given the significant impact of depression on survival among patients with lung cancer, additional funding and resources are urgently needed to combat this debilitating comorbid disease.

Acknowledgments
This project was supported in part by the National Cancer Institute of the National Institutes of Health under award K07CA190706 to Dr. Sullivan, a Career Development Award from the Veterans Health Administration Health Service Research and Development (CDA 14-428) to Dr. Teo and the HSR&D Center to Improve Veteran Involvement in Care (CIVIC) (CIN 13-404) at the VA Portland Health Care System.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The VA had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The opinions expressed herein are those of the authors and do not necessarily reflect those of
Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies.

Click here to read the digital edition.

Pages

Recommended Reading

Pembrolizumab ‘new standard of care’ in advanced PD-L1-rich NSCLC
Federal Practitioner
Rare Cancer Gets Timely Right Treatment
Federal Practitioner
Quality of Supportive Care for Patients With Advanced Lung Cancer in the VHA
Federal Practitioner
Complex Malignancies: A Diagnostic and Therapeutic Trilemma
Federal Practitioner
Lung Cancer Screening: Translating Research Into Practice (FULL)
Federal Practitioner
VA Partnership Expands Access to Lung Screening Programs
Federal Practitioner
Timeliness of Lung Cancer Diagnosis and Treatment (FULL)
Federal Practitioner
Clinical Puzzle: Lung Cancer or Hodgkin Lymphoma?
Federal Practitioner
Former Smokers Motivate Quitters
Federal Practitioner
Rapid EGFR testing reduces time to therapy for patients with NSCLC
Federal Practitioner